Employment Type : Full-Time
Why Seres Therapeutics What You’ll Bring You May Also Bring Seres is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation, or any characteristic protected under applicable law. Job Type: Full-time Work Location: Multiple Locations
Seres Therapeutics is a leading microbiome therapeutics platform company developing a novel class of multifunctional bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. Our SER-109 program achieved the first-ever positive pivotal clinical results for a targeted microbiome drug candidate and has obtained Breakthrough Therapy and Orphan Drug designations from the FDA. The SER-109 program is being advanced for the treatment of recurrent C. difficile infection and has potential to become a first-in-class FDA-approved microbiome therapeutic.
Seres Therapeutics is a member of the Flagship Pioneering family of companies.
Position Summary
At Seres, we’re leading the microbiome revolution — and our most revolutionary asset is our team. Their courage and deep commitment are what drives us on our mission to transform the lives of patients worldwide with revolutionary microbiome therapeutics.
Reporting to the Associate Director, Analytical Development, you will be responsible for developing methods to ensure safe and effective bacterial therapeutics for the patients who need them. You will need to apply your expertise to the unique challenges faced when characterizing and releasing therapeutics comprised of communities of bacteria. As Seres has grown, the need for assays that can match the throughput of a robust product pipeline has also grown. You will be instrumental in designing the assays, technologies, and data processing that will allow Seres to efficiently characterize and release our products.
What You’ll Do